Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate

Aug.21.2025
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Lead: Spain's proposed e-cigarette and nicotine pouch restrictions face strong opposition from seven EU countries and the European Commission.

Key points: 

 

·The proposal includes banning e-cigarette flavors other than tobacco and limiting the nicotine content in pouches to 0.99 milligrams per pouch. 

·EU reaction: Seven countries and the European Commission oppose the law, believing it violates the principle of free movement of goods. 

·Legal background: According to the EU principle of mutual recognition, a product legally sold in one member state should generally be allowed in other member states unless there are legitimate reasons. 

·Expert opinions: Patrik Strömer, Secretary General of the Swedish Snuff Manufacturers Association, criticized the lack of scientific basis for the law, calling it an ideological gesture. 

·Commission warning: Sandra Gallina, Director-General of DG SANTE at the European Commission, warned that some proposed restrictions are poorly designed and may backfire, harming public health. 

·Member states' positions: Countries like Italy and Greece strongly criticized the law, believing it is fundamentally inconsistent with the principle of free movement of goods in the European single market. 

·Spanish stance: Despite opposition, Spain is refusing to amend the law, leading to tension within the EU. 

·Future prospects: The matter now rests with the European Commission, which may demand Spain to modify the text or face the prospect of member states challenging Madrid in court.

 


 

According to a report from European Conservative on August 20th, the Spanish Health Ministry led by the far-left party Podemos has caused a stir in Brussels by proposing a draft law. The law would impose extensive restrictions on e-cigarette products and nicotine pouches, which several European Union member states believe violate the basic principle of free movement of goods.

 

The proposal includes banning e-cigarette flavors other than tobacco and imposing strict limits on nicotine content, setting the maximum nicotine content per pouch at 0.99 milligrams, effectively banning the use of nicotine pouches. Currently, nicotine pouches are in a regulatory grey area not clearly covered by the EU Tobacco Products Directive (TPD), giving member states broad discretion on the matter.

 

So far, the plan has been deadlocked due to strong opposition from seven countries including Hungary, Italy, Romania, Sweden, Greece, Czech Republic, Croatia, as well as the European Commission. According to the EU's principle of mutual recognition, a product legally sold in one member state should generally be allowed in other member states unless there are genuine reasons. Currently, 18 member states offer e-cigarettes in flavors other than tobacco, while nicotine pouches are sold in 13 member states.

 

This is a posture on ideology, not a serious public health policy," said Patrik Strömer, Secretary General of the Swedish Snuff Manufacturers Association. He believes that Spain's arguments lack scientific rigor and fail to meet EU proportionality standards. He stated that Spain's arguments rely on alarmist rhetoric and selectively chosen data, rather than the latest risk assessments. "They refer to tobacco as an 'epidemic,' which is a misleading analogy... tobacco use is not a contagious disease. And within the OECD, nicotine consumption is decreasing, not increasing.

 

Sandra Gallina, Director General of Health and Food Safety at the European Commission, has written to the Spanish Minister of Foreign Affairs warning that some proposed restriction measures are so poorly designed that they may actually have the opposite effect and harm public health. One example is Spain's plan to only ban unsafe e-cigarette ingredients that are already on the existing EU chemical list, which could allow other dangerous substances to slip through unregulated.

 

Italy has issued one of the strongest condemnations, stating that "the provisions in Spain's legislation are in serious inconsistency with the fundamental principle of free movement of goods in the European single market. This measure will introduce trade barriers within the internal market, which will have a negative impact on the key coordination goals set by European law.

 

Greece also echoed the criticism and urged for revisions, stating: "We demand that Spain modify the above provisions to ensure they not only align with the goals of public health protection, but also with the basic principles of free movement of goods and fair competition.

 

In Brussels, Spain is sticking to its guns and refusing to modify the law, despite these concerns, which has surprised many. Typically, member states adjust draft measures after receiving feedback from EU partners and the Commission. Stakeholders from countries like Romania are surprised by Madrid's inflexibility.

 

Currently, this matter has been handed over to the committee, which can request Spain to modify the text or face the prospect of member states challenging Madrid in court. With tensions escalating, this dispute highlights the delicate balance between national health policies and the core EU principle of market freedoms, potentially leading to a legal showdown for Spain in Luxembourg.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Philip Morris International (PMI) introduced TEREA Bold Red and Bold Black heated tobacco sticks in Germany in October 2026, both carrying a brand-rated tobacco-flavor intensity of 10, the highest level in the country's TEREA portfolio. Bold Red features leather and warm woody notes, while Bold Black combines woody and subtle floral notes. Both are sold in 20-stick packs at €8, approximately 2.6% above standard TEREA products. Germany's TEREA range now includes 11 flavor variants, alongside a separate 26-stick XL format priced at €10. IQOS Germany announced the new products on October 12, followed by a phased retail rollout from late October and an IQOS Club campaign running through December.
product
Nov.02